Acknowledgement
This study was supported by a grant from the National Research Foundation (NRF) of Korea, funded by the government of the Republic of Korea (NRF-2021R1A2C1007054).
References
- Tavasoly A, Golshahi H, Rezaie A, Farhadi M. Classification and grading of canine malignant mammary tumors. Vet Res Forum 2013;4(1):25-30.
- Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895-902. https://doi.org/10.1038/nrc1232
- Aponte PM, Caicedo A. Stemness in cancer: stem cells, cancer stem cells, and their microenvironment. Stem Cells Int. 2017;2017:5619472. https://doi.org/10.1155/2017/5619472
- Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20(56):8085-8091. https://doi.org/10.1038/sj/onc/1205088
- Zhao W, Ji X, Zhang F, Li L, Ma L. Embryonic stem cell markers. Molecules. 2012;17(6):6196-6236. https://doi.org/10.3390/molecules17066196
- Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun. 2009;383(2):157-162. https://doi.org/10.1016/j.bbrc.2009.02.156
- Misdorp W, Else R W, Hellmen E, Lipscomb TP. Histological Classification of Mammary Tumors of the Dog and the Cat. Washington, D.C.: Armed Forces Institute of Pathology and the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology; 1999, 11-29.
- Cassali GD, Lavalle GE, de Nardi AB, Ferreira E, Bertagnolli AC, Estrela-Lima A, et al. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Braz J Vet Pathol. 2011;4(2):153-180.
- Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993;4(4):219-229. PUBMED
- Varallo GR, Gelaleti GB, Maschio-Signorini LB, Moschetta MG, Lopes JR, De Nardi AB, et al. Prognostic phenotypic classification for canine mammary tumors. Oncol Lett. 2019;18(6):6545-6553.
- Restucci B, Papparella S, De Vico G, Maiolino P. E cadherin expression in normal and neoplastic canine mammary gland. J Comp Pathol. 1997;116(2):191-202. https://doi.org/10.1016/S0021-9975(97)80076-X
- Sarli G, Preziosi R, De Tolla L, Brunetti B, Benazzi C. E-cadherin immunoreactivity in canine mammary tumors. J Vet Diagn Invest. 2004;16(6):542-547. https://doi.org/10.1177/104063870401600608
- Reis AL, Carvalheira J, Schmitt FC, Gartner F. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Vet Rec. 2003;152(20):621-624. https://doi.org/10.1136/vr.152.20.621
- Rodo A, Malicka E. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches. Pol J Vet Sci. 2008;11(1):47-54.
- Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis. 2005;26(5):943-950. https://doi.org/10.1093/carcin/bgi070
- Di D, Chen L, Wang L, Sun P, Liu Y, Xu Z, et al. Downregulation of human intercellular adhesion molecule-1 attenuates the metastatic ability in human breast cancer cell lines. Oncol Rep. 2016;35(3):1541-1548. https://doi.org/10.3892/or.2016.4543
- El-Sherbiny YM, Cox MC, Ismail ZA, Shamsuddin AM, Vucenik I; EI-Sherbiny YM. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res 2001;21(4A):2393-2403.
- Ren X, Long M, Li Z, Wu B, Jin T, Tu C, et al. Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway. Cell Death Dis. 2020;11(6):464. https://doi.org/10.1038/s41419-020-2640-8
- Li F, Zhang C, Fu L. PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway. PLoS One. 2019;14(10):e0218839. https://doi.org/10.1371/journal.pone.0218839
- Moschetta MG, Maschio LB, Jardim-Perassi BV, Gelaleti GB, Lopes JR, Leonel C, et al. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors. Oncol Rep. 2015;33(5):2345-2353. https://doi.org/10.3892/or.2015.3856
- Chaiyawat P, Phanphaisarn A, Sirikaew N, Klangjorhor J, Thepbundit V, Teeyakasem P, et al. IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma. Sci Rep. 2021;11(1):10887. https://doi.org/10.1038/s41598-021-90456-4
- J Sedano M, I Ramos E, Choudhari R, L Harrison A, Subramani R, Lakshmanaswamy R, et al. Hypoxanthine phosphoribosyl transferase 1 is upregulated, predicts clinical outcome and controls gene expression in breast cancer. Cancers (Basel). 2020;12(6):1522. https://doi.org/10.3390/cancers12061522
- Wei F, Ding L, Wei Z, Zhang Y, Li Y, Qinghua L, et al. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells. Oncotarget. 2016;7(51):85259-85272. https://doi.org/10.18632/oncotarget.13269
- Lu X, Gao C, Liu C, Zhuang J, Su P, Li H, et al. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis. Pathol Res Pract. 2019;215(8):152475. https://doi.org/10.1016/j.prp.2019.152475
- Han N, Li W, Zhang M. The function of the RNA-binding protein hnRNP in cancer metastasis. J Cancer Res Ther. 2013;9 Suppl:S129-S134.
- Vargas TH, Pulz LH, Barra CN, Kleeb SR, Xavier JG, Catao-Dias JL, et al. Immunohistochemical expression of the pluripotency factor OCT4 in canine mast cell tumours. J Comp Pathol. 2015;153(4):251-255. https://doi.org/10.1016/j.jcpa.2015.08.010
- Gatti M, Solari A, Pattarozzi A, Campanella C, Thellung S, Maniscalco L, et al. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Exp Cell Res. 2018;363(1):48-64. https://doi.org/10.1016/j.yexcr.2018.01.002
- Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J. 2008;175(1):69-75. https://doi.org/10.1016/j.tvjl.2007.07.025
- Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010;70(24):10433-10444. https://doi.org/10.1158/0008-5472.CAN-10-2638
- Yang F, Zhang J, Yang H. OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients. Onco Targets Ther. 2018;11(11):7873-7881. https://doi.org/10.2147/OTT.S173522
- Webster JD, Yuzbasiyan-Gurkan V, Trosko JE, Chang CC, Kiupel M. Expression of the embryonic transcription factor Oct4 in canine neoplasms: a potential marker for stem cell subpopulations in neoplasia. Vet Pathol. 2007;44(6):893-900. https://doi.org/10.1354/vp.44-6-893
- Yu B, Cai H, Xu Z, Xu T, Zou Q, Gu M. Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance. Artif Cells Nanomed Biotechnol. 2016;44(8):1818-1823. https://doi.org/10.3109/21691401.2015.1105238
- Li X, Wang J, Xu Z, Ahmad A, Li E, Wang Y, et al. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci. 2012;13(6):7663-7675. https://doi.org/10.3390/ijms13067663
- Gwak JM, Kim M, Kim HJ, Jang MH, Park SY. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. Oncotarget. 2017;8(22):36305-36318. https://doi.org/10.18632/oncotarget.16750
- Hatefi N, Nouraee N, Parvin M, Ziaee SA, Mowla SJ. Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer. Iran J Basic Med Sci 2012;15(6):1154-1161.
- Wang Q, He W, Lu C, Wang Z, Wang J, Giercksky KE, et al. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Res 2009;29(4):1233-1241.
- Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, et al. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res. 2012;174(1):130-135. https://doi.org/10.1016/j.jss.2010.11.903
- Chen Y, Huang Y, Huang Y, Chen J, Wang S, Zhou J. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis. PLoS One. 2013;8(8):e71140. https://doi.org/10.1371/journal.pone.0071140
- Pham DL, Scheble V, Bareiss P, Fischer A, Beschorner C, Adam A, et al. SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol. 2013;32(4):358-367. https://doi.org/10.1097/PGP.0b013e31826a642b
- Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer. 2002;95(11):2346-2352. https://doi.org/10.1002/cncr.10963
- Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 2005;104(10):2092-2098. https://doi.org/10.1002/cncr.21435
- Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704-715. https://doi.org/10.1016/j.cell.2008.03.027
- Bareiss PM, Paczulla A, Wang H, Schairer R, Wiehr S, Kohlhofer U, et al. SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res. 2013;73(17):5544-5555. https://doi.org/10.1158/0008-5472.CAN-12-4177
- Lin T, Ding YQ, Li JM. Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma. Med Oncol. 2012;29(2):878-885. https://doi.org/10.1007/s12032-011-9860-9